Be in the know. 15 key reads for Monday…

  1. Why Vaccine Makers Could Benefit From Mandates (Barron’s)
  2. Chinese Stocks Jump as Beijing Signals More Economic Support (Bloomberg)
  3. Pfizer and Moderna ramp up EU Covid vaccine prices (Financial Times)
  4. Proxy Season Is Winding Down, but Activist Opportunities Still Abound (Barron’s)
  5. Li Auto Posts Huge Deliveries. Good News for EVs as Chip Shortage Abates. (Barron’s)
  6. The Cost of Becoming an Olympic Swimmer for Team USA (Wall Street Journal)
  7. Behind the Rise of U.S. Solar Power, a Mountain of Chinese Coal (Wall Street Journal)
  8. Eviction Ban’s Expiration Leaves Renters in South Appearing Most Vulnerable (Wall Street Journal)
  9. Tide of U.S. Debt Set to Recede, Countering Effect of Fed Taper (Bloomberg)
  10. Nuclear Power Could Get Lifeline in Senate Infrastructure Bill (Bloomberg)
  11. FDA Under Pressure to Grant Full Approval to Covid-19 Vaccines (Wall Street Journal)
  12. Senate unveils $1 trillion bipartisan infrastructure bill, vote expected within days (MarketWatch)
  13. Ray Dalio says Chinese stocks still ‘important part’ of a portfolio after crackdown (MarketWatch)
  14. ‘A great time to buy,’ says one Wall Street analyst as Amazon shares tumble on disappointment (MarketWatch)
  15. Brazil manufacturing PMI rises to 5-month high in July, IHS Markit says (Reuters)